A comparison of oral and topical corticosteroids in patients with bullous pemphigoid

New England Journal of Medicine

Volumn 346, Issue 5, 2002, Pages 321-327

  Joly, Pascal ^a,k   Roujeau, Jean Claude ^b   Benichou, Jacques ^a   Picard, Catherine ^c   Dreno, Brigitte ^d   Delaporte, Emmanuel ^e   Vaillant, Loïc ^f   D'Incan, Michel ^g   Plantin, Patrice ^h   Bedane, Christophe ⁱ   Young, Paul ^a   Bernard, Philippe ^j  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c Bichat University   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e UNIV LILLE   (France)

^f UNIVERSITÉ DE TOURS   (France)

^g UNIVERSITÉ CLERMONT AUVERGNE   (France)

^h General Hospital of Quimper   (France)

ⁱ UNIVERSITY OF LIMOGES   (France)

^j UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^k HÔPITAL CHARLES NICOLLE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CORTICOSTEROID; PREDNISONE; PREDNISONE ACETATE;

AGED; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CELLULITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DELIRIUM; DIABETES MELLITUS; DISEASE SEVERITY; DRUG POTENCY; DRUG TOLERABILITY; FEMALE; FRACTURE; HEART FAILURE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEMPHIGOID; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; STROKE; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; CLOBETASOL; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; OINTMENTS; PEMPHIGOID, BULLOUS; PREDNISONE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SURVIVAL RATE;

EID: 0037204199     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa011592     Document Type: Article

References (35)

1. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions
2. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany
3. Bullous pemphigoid: The latest in diagnosis, prognosis, and therapy
4. Evaluation des critères histologiques de pemphigoïde bulleuse: Relation avec les antigènes reconnu en immunotransfert par les autoanticorps anti-epiderme
5. Direct immunofluorescence studies of sodium chloride- separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita
6. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid
7. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies
8. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera: Immunolocalization of this protein to the hemidesmosome
9. Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins
10. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180
11. High risk of death in elderly patients with extensive bullous pemphigoid
12. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: A cohort analysis of 94 elderly patients
13. The use of chlorambucil in the treatment of bullous pemphigoid
14. Evaluation of clinical criteria for diagnosis of bullous pemphigoid
15. Management of acquired bullous skin diseases
16. Pronostic vital de la pemphigoïde: Analyse d'une cohorte de 78 malades
17. Lack of predictive factors for the clinical course of bullous pemphigoid
18. The events leading to the death of patients with pemphigus and pemphigoid
19. Azathioprine plus prednisone in treatment of pemphigoid
20. Azathioprine in treatment of bullous pemphigoid
21. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients
22. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid
23. Effects of cyclosporin on bullous pemphigoid and pemphigus
24. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid
25. Bullous pemphigoid treated with mycophenolate mofetil
26. Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases
27. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid
28. Treatment of bullous pemphigoid with topical clobetasol propionate
29. Bullous pemphigoid treated by topical corticosteroids
30. Étude prospective du traitement de la pemphigoide par un dermocorticoïde classe I
31. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients
32. Some factors affecting prognosis in pemphigus vulgaris and pemphigoid
33. The complications of systemic corticosteroid therapy in the elderly: A retrospective study
34. Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid